When promoting another company highlighting a dark company is not a good idea. We know why UNVC is dark but a Euromed partner or investor wouldn't care to look any further to understand why its dark. Also why list a company that is in the process of changing names. Again, it just adds questions to whoever is looking at Euromed. Just my opinion as to why thats not a big deal.

As for Doc not being a good communicator I'm kind of scratching my head. With UNVC yes he is not communicating well but there are multiple reasons for that.

You do not get to Doc's position without being a good communicator. Think of all the boards he's served and is serving on. Dr. Dalton is one of the original members and directors of the National Council of Prescription Drug Programs (NCPDP) and responsible for the standards that pharmacies use across the United States to transmit prescriptions.

Dr. Dalton has served as a board member on such organizations as Blue Shield of Pennsylvania, United Way, National Health Association, National Association of Chain Drug Stores, (NACDS) .

He has been a visiting professor and lectures at several schools of pharmacy throughout the United States. Theres more too, but I think you get the point.

Doc is not like the other CEO'S out there that will sell your own soul for you. Its hard push out those fears. I know cause I still have them too. He's building something that I don't quite understand but I believe its going to be well worth it.